Global (En)
About
About
Our Company
Leadership
History
Contact & Locations
News
News
Patients
Patients
Resources & Links
Patient Advocacy
Patient Stories
Healthcare Professionals
Healthcare Professionals
Medical Affairs
Clinical Trials
Resources
Investigator-Initiated Trials
Products
Products
Technology
Research
Manufacturing
Pipeline
Overview
Disease States
Disease States
Pipeline
Publications
Investors
Clinical Trials
Careers
ESG
Contact & Locations
Back
Current Regions and Language
Global Website
English
Taiwan (HQ)
English
繁中
US
English
Japan
日本語
Korea
한국어
News
．
Material Information - The Health Canada has Accepted the New Drug Submission of Ropeginterferon alfa-2b for PV
Sep 11, 2025
Download
Material Information - The Health Canada has Accepted the New Drug Submission of Ropeginterferon alfa-2b for PV
Previous
Next
